| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.002 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.003 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.44 | 0.003 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.096 | 0.003 |